No profile data available.
Biodesix, Inc. (BDSX) is a healthcare company in the medical testing laboratories industry, based in Louisville, United States, with about 334 full-time employees.
It reported revenue of $88.50 million for fiscal year 2025, up 24.1% from fiscal year 2024, and net income of -$35.27 million. Its market capitalization was $274.54 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Biodesix, Inc. operates as a diagnostic solutions company.
Biodesix reported $88.50 million in revenue for fiscal year 2025, up 24.1% from $71.32 million in fiscal year 2024.
$274.54 million as of October 9, 2026.
Listed companies of a similar size in the same industry (medical testing laboratories) include Opko Health, Inc. (OPK), Fulgent Genetics, Inc. (FLGT), Prenetics Global Limited (PRE), Lucid Diagnostics Inc. (LUCD).